In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Modern partnerships with CROs
In this article in Contract Pharma, ICON SMEs share insight on strategic and blended outsourcing models and trends in today’s market.
-
Driving progress in reducing kit wastage
In this article from European Pharmaceutical Manufacturer,Leonard Wee, VP, Global Supply Chain, Laboratories, explores how shifting to more reliable kit forecasting, in tandem with efficient kit building practices, can help reduce waste, cost and logistical requirements.
-
Integration of AI in imaging clinical trials
In this article from Drug Discovery World, Sophie Winandy, Executive Director of Medical Imaging, explores the benefits of AI and how it can be integrated throughout medical imaging within clinical trials.
-
Logistical considerations in mRNA vaccine development
In this article, ICON’s Andreas Dreps and Martin Lachs discuss the logistical considerations in mRNA vaccine development.
©BioPharm International
-
.jpg?w=545&itok=9OvhnaiJ "EPR in healthcare news.")
Considerations for safety data migration methods
In this article, Graeme Bones, Director of Pharmacovigilance, explains how to handle the different types of data migration methods and how companies can select the optimum approach to ensure data integrity is maintained.
-
Beyond the glass: A look at digital pathology’s practical applications and novel possibilities in clinical trials
In this article from Diagnostics World News, Jenny Ross, Pathologist and Medical Director, looks at practical uses of digital pathology technologies and illustrates considerations for their use in global clinical trials.
-
AI In Clinical Research: Now And Beyond
In this piece from Forbes, Dr. Greg Licholai, Chief Medical and Chief Innovation Officer talks about recent developments, regulatory considerations, and the promising future of AI in clinical research are reshaping the landscape of drug development and patient care.
-
ICON partners with US Government for clinical trials of Covid-19 vaccines
The article on Clinical Trials Arena reports that ICON will conduct a phase 2b clinical trial for the US BARDA-selected Covid-19 vaccine candidate as part of Project NextGen.
-
BARDA, ICON partner to execute next-gen COVID vaccine trial
This news article from Contract Pharma reports that ICON will execute a Phase 2b clinical trial to assess the relative efficacy of a next generation COVID-19 vaccine.
-
ICON in pact with BARDA for next-gen COVID vaccine trial
The piece from Seeking Alpha highlights that the trial is designed to evaluate the vaccine candidate selected by BARDA, which functions as part of the Administration for Strategic Preparedness and Response under the U.S. Department of Health and Human Services.
.jpg?w=340&itok=CMP4WAsy "EPR in healthcare news."){kind=icon}
